Heart Disease Clinical Trials in Cleveland

Showing 241-254 of 254 trials

Biomarkers in Acute Heart Failure

NCT00537628

Primary Objectives 1. Mid Region pro Adrenomedullin (MR-proADM) is superior to BNP for the prognosis of heart failure (HF) patients and adds incremental value in predicting outcomes for patients presenting to the Emergency Department (ED) with shortness of breath. 2. Mid Region pro A-Type Natriuretic Peptide (MR-proANP) is non-inferior to BNP for the diagnosis of HF in patients presenting to the ED with shortness of breath.

Shortness of BreathHeart Failure

Brahms AG1,641 participantsStarted Mar 2007

San Diego, California, United States • San Diego, California, United States • San Francisco, California, United States +12 more locations

TERMINATED< 1 mile

Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent

NCT00584714

The purpose of this study is to collect longer term follow-up information concerning health and survival on selected patients who received PB127 for injectable suspension in the pivotal trial (127-014).

Coronary Artery Disease

Point Biomedical300 participantsStarted Oct 2007

Tucson, Arizona, United States • Burlingame, California, United States • Long Beach, California, United States +36 more locations

Biomarkers in Acute Heart Failure

Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent

Heart Disease Trials in Other Cities

MYOHEART™ (Myogenesis Heart Efficiency and Regeneration Trial)

A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels

Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.

ARISE - Aggressive Reduction of Inflammation Stops Events

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)

Attain StarFix™ Model 4195 Left Ventricular Lead

A Phase I Study to Assess the Electrophysiologic Effects of BMS-394136 on the Atrium and Ventricle in Patients With Dual-Chamber Pacemakers or Defibrillators

Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function

PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease

Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection

D2-EPG Study: Evaluation of New Sensing Circuitry and Capture Management

An Observational Study of Burden of Upper GI-Symptoms in CV Risk Patients

Other Conditions in Cleveland